메뉴 건너뛰기




Volumn 195, Issue 3, 2006, Pages 839-842

Gestational age at abortion: The impact of first-trimester risk assessment for aneuploidy

Author keywords

Abortion; Aneuploidy; Prenatal diagnosis; Risk assessment

Indexed keywords

ABORTION; ADULT; ANEUPLOIDY; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RANK SUM TEST; RISK ASSESSMENT; TRISOMY; TRISOMY 13; TRISOMY 18; TRISOMY 21; TRISOMY 45X;

EID: 33747885759     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.038     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0032883373 scopus 로고    scopus 로고
    • Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review
    • Mansfield C., Hopfer S., and Marteau T.M. Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. Prenat Diagn 19 (1999) 808-812
    • (1999) Prenat Diagn , vol.19 , pp. 808-812
    • Mansfield, C.1    Hopfer, S.2    Marteau, T.M.3
  • 4
    • 0037266918 scopus 로고    scopus 로고
    • The accessibility of abortion services in the United States, 2001
    • Henshaw S.K., and Finer L.B. The accessibility of abortion services in the United States, 2001. Perspect Sex Reprod Health 35 (2003) 16-24
    • (2003) Perspect Sex Reprod Health , vol.35 , pp. 16-24
    • Henshaw, S.K.1    Finer, L.B.2
  • 8
    • 0032146382 scopus 로고    scopus 로고
    • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
    • Snijders R.J., Noble P., Sebire N., Souka A., and Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352 (1998) 343-346
    • (1998) Lancet , vol.352 , pp. 343-346
    • Snijders, R.J.1    Noble, P.2    Sebire, N.3    Souka, A.4    Nicolaides, K.H.5
  • 9
    • 3042781386 scopus 로고    scopus 로고
    • First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin
    • Yaron Y., Ochshorn Y., Tsabari S., and Shira A.B. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin. Prenat Diagn 24 (2004) 445-450
    • (2004) Prenat Diagn , vol.24 , pp. 445-450
    • Yaron, Y.1    Ochshorn, Y.2    Tsabari, S.3    Shira, A.B.4
  • 10
    • 0041589349 scopus 로고    scopus 로고
    • First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population
    • Chasen S.T., Sharma G., Kalish R.B., and Chervenak F.A. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population. Ultrasound Obstet Gynecol 22 (2003) 149-151
    • (2003) Ultrasound Obstet Gynecol , vol.22 , pp. 149-151
    • Chasen, S.T.1    Sharma, G.2    Kalish, R.B.3    Chervenak, F.A.4
  • 11
    • 29544437559 scopus 로고    scopus 로고
    • Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials
    • Perni S.C., Predanic M., Kalish R.B., Chervenak F.A., and Chasen S.T. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials. Am J Obstet Gynecol 194 (2006) 127-130
    • (2006) Am J Obstet Gynecol , vol.194 , pp. 127-130
    • Perni, S.C.1    Predanic, M.2    Kalish, R.B.3    Chervenak, F.A.4    Chasen, S.T.5
  • 12
    • 1642464786 scopus 로고    scopus 로고
    • Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    • Chasen S.T., McCullough L.B., and Chervenak F.A. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?. Am J Obstet Gynecol 190 (2004) 769-774
    • (2004) Am J Obstet Gynecol , vol.190 , pp. 769-774
    • Chasen, S.T.1    McCullough, L.B.2    Chervenak, F.A.3
  • 13
    • 0034987147 scopus 로고    scopus 로고
    • Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older
    • Zoppi M.A., Ibba R.M., Putzolu M., Floris M., and Monni G. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 97 (2001) 916-920
    • (2001) Obstet Gynecol , vol.97 , pp. 916-920
    • Zoppi, M.A.1    Ibba, R.M.2    Putzolu, M.3    Floris, M.4    Monni, G.5
  • 14
    • 0028849426 scopus 로고
    • Maternal age and gestational age-specific risk for chromosomal defects
    • Snijders R.J., Sebire N.J., and Nicolaides K.H. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 10 (1995) 356-367
    • (1995) Fetal Diagn Ther , vol.10 , pp. 356-367
    • Snijders, R.J.1    Sebire, N.J.2    Nicolaides, K.H.3
  • 15
    • 23644445294 scopus 로고    scopus 로고
    • Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21
    • Nicolaides K.H., Chervenak F.A., McCullough L.B., Avgidou K., and Papageorghiou A. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 193 (2005) 322-326
    • (2005) Am J Obstet Gynecol , vol.193 , pp. 322-326
    • Nicolaides, K.H.1    Chervenak, F.A.2    McCullough, L.B.3    Avgidou, K.4    Papageorghiou, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.